**Question:** All are pharmacogenetic conditions, except -

A. Cystic Fibrosis
B. Huntington's Disease
C. Beta-Thalassemia
D. Parkinson's Disease

**Core Concept:** Pharmacogenetics is the study of how genetic variations affect an individual's response to drugs. Pharmacogenetic conditions are diseases caused by genetic variations that alter drug response.

**Why the Correct Answer is Right:**
D. Parkinson's Disease is a neurodegenerative disorder primarily caused by the loss of dopaminergic neurons in the substantia nigra and is not primarily related to drug response. Although certain medications may be used in its management (e.g., L-dopa), the condition itself is not a pharmacogenetic condition.

**Why Each Wrong Option is Incorrect:**
A. Cystic Fibrosis is caused by mutations in the CFTR gene, leading to impaired ion transport. It results in altered drug absorption and secretion, making it a pharmacogenetic condition.
B. Huntington's Disease is caused by an expansion of a CAG trinucleotide repeat in the HTT gene, leading to protein dysfunction and neuronal death. It is not primarily related to drug response, making it not a pharmacogenetic condition.
C. Beta-Thalassemia is caused by mutations in the HBB gene, leading to abnormal hemoglobin synthesis. This results in altered red blood cell life span and reduced capacity to carry oxygen, but it is not directly related to drug response, making it not a pharmacogenetic condition.

**Clinical Pearl:**
Understanding pharmacogenetics is crucial in personalized medicine, where treatment decisions are based on an individual's genetic makeup. It ensures optimal efficacy and reduces adverse drug reactions by tailoring drug therapy to an individual's genetic profile. However, it is essential to note that pharmacogenetic conditions are a small subset of the broader field of pharmacogenomics, which includes not only gene-drug interactions but also gene-gene interactions and gene-environment interactions.

**Correct Answer:**
D. Parkinson's Disease (Parkinson's disease)

**Why D is Right:** As mentioned earlier, Parkinson's disease is not a pharmacogenetic condition. Although certain medications like levodopa and dopamine agonists are used in its management, the condition itself is not primarily related to drug response.

**Why the Other Options are Wrong:**
A. Cystic Fibrosis: This condition is a pharmacogenetic disease, as it results from genetic mutations affecting drug absorption and secretion, leading to altered drug response.
B. Huntington's Disease: This condition is not a pharmacogenetic disease, as it is caused by genetic mutations leading to neuronal dysfunction and is not directly related to drug response.
C. Beta-Thalassemia: Similar to Huntington's Disease, this condition is caused by genetic mutations leading to abnormal hemoglobin synthesis and is not directly related to drug response.